TTY Biopharm Co Ltd Financial Flexibility Index
TTY Biopharm Co Ltd financial flexibility index. TTY Biopharm Co Ltd (4105) has a Financial Flexibility Index of 0.18x as of March 2026. Free cash flow of NT$782.44 Million (operating CF NT$654.16 Million minus capex NT$128.28 Million) represents 0% of total liabilities (NT$4.28 Billion). See free cash flow generation of TTY Biopharm Co Ltd to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of TTY Biopharm Co Ltd (2017–2025)
Financial flexibility index of TTY Biopharm Co Ltd from 2017 to 2025. Historical Financial Flexibility Index trend for TTY Biopharm Co Ltd across 9 annual periods. Check TTY Biopharm Co Ltd (4105) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
TTY Biopharm Co Ltd Financial Flexibility Index by Year (2017–2025)
TTY Biopharm Co Ltd financial flexibility index by year from 2017 to 2025. Year-by-year free cash flow to debt coverage for TTY Biopharm Co Ltd. For the full cash flow conversion analysis, see cash flow conversion of TTY Biopharm Co Ltd.
| Year | Flexibility Index | Free Cash Flow (TWD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.58x | NT$1.91 Billion | NT$1.76 Billion | NT$3.30 Billion | ▲ +31.1% |
| 2024 | 0.44x | NT$1.48 Billion | NT$1.35 Billion | NT$3.35 Billion | ▲ +25.8% |
| 2023 | 0.35x | NT$1.18 Billion | NT$1.09 Billion | NT$3.37 Billion | ▼ -13.6% |
| 2022 | 0.41x | NT$1.37 Billion | NT$1.24 Billion | NT$3.37 Billion | ▲ +8.0% |
| 2021 | 0.38x | NT$1.33 Billion | NT$1.26 Billion | NT$3.53 Billion | ▲ +74.7% |
| 2020 | 0.22x | NT$708.21 Million | NT$526.35 Million | NT$3.28 Billion | ▼ -43.0% |
| 2019 | 0.38x | NT$1.28 Billion | NT$1.21 Billion | NT$3.38 Billion | ▼ -12.3% |
| 2018 | 0.43x | NT$1.15 Billion | NT$1.07 Billion | NT$2.66 Billion | ▲ +33.9% |
| 2017 | 0.32x | NT$1.09 Billion | NT$996.52 Million | NT$3.40 Billion | — |